Summary
Despite considerable research we still do not have a comprehensive explanation for the pathogenesis of diabetic neuropathy. Although chronic hyperglycaemia is almost certainly involved, it is not known whether the primary pathology is metabolic, microvascular, or an interaction between the two. Hyperglycaemia-induced polyol pathway hyperactivity associated with nerve sorbitol accumulation and myo-inositol depletion may play a part in the genesis of diabetic neuropathy. The case for microvascular disease in diabetic neuropathy is now strong. Fibre loss in human sural nerve is multifocal, suggesting ischaemia. The degree of vessel disease has been related to the severity of neuropathy. People with chronic obstructive pulmonary disease develop the so called “hypoxic neuropathy” in which similar microvascular changes occur as in diabetic neuropathy. In rats with experimental diabetic neuropathy nerve blood flow is reduced and oxygen supplementation or vasodilator treatment improved the deterioration in conduction velocity and nerve blood flow. Similarly, in human diabetic neuropathy, there is impaired nerve blood flow, epineurial arterio-venous shunting and a reduction in sural nerve oxygen tension. At what stage during the development of nerve damage these changes occur is yet to be determined.
Article PDF
Similar content being viewed by others
Abbreviations
- RICF:
-
resistance to ischaemic conduction failure
References
Ward JD, Goto Y (1990) Diabetic neuropathy. John Wiley and Sons, Chichester
Ward JD (1982) The diabetic leg. Diabetologia 22: 141–147
Watkins PJ (1984) Pain and diabetic neuropathy. BMJ 288: 168–169
Archer AG, Watkins PJ, Thomas PK, Sharma AK, Payan J (1983) The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry 26: 491–499
Tesfaye S, Malik R, Harris N, Jakubowski J, Mody C, Ward JD (1993) Painful and severe autonomic neuropathy following insulin: further evidence for microvascular disease in neuropathy. Diabetes 42: 196A (Abstract)
Tomlinson DR (1992) The pharmacology of diabetic neuropathy. Diabetes Metab Rev 8: 67–84
Harati Y (1987) Diabetic peripheral neuropathies. Annals Inter Med 107: 546–559
Young RJ (1993) Structural functional interactions in the natural history of diabetic polyneuropathy: a key to the understanding of neuropathic pain? Diabetic Med 10 [Suppl 2]: 89S-90S
Vinik AI, Holland MT, Le Beau JM, Liuzzi FJ, Stansberry KB, Colen LB (1992) Diabetic neuropathies. Diabetes Care 15: 1926–1975
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med 329: 977–986
Tesfaye S, Stevens L, Stephenson J, Ward JD on behalf of the EURODIAB IDDM Study Group (1993) The prevalence of diabetic neuropathy and its relation to glycaemic control in insulin dependent subjects in Europe. Diabetologia 36 [Suppl 1]: A176 (Abstract)
Pirart J (1978) Diabetes mellitus and its degenerative complications: a prospective study of 4400 patients observed between 1947 and 1973. Diabetes Care 1: 168–188 and 252–263
Ward JD, Barnes CG, Fisher DJ, Jessop JD, Baker RWR (1971) Improvement in nerve conduction following treatment in newly diagnosed diabetics. Lancet I: 428–430
Boulton AJM, Drury J, Clarke B, Ward JD (1982) Continuous subcutaneous insulin infusion in the management of painful diabetic neuropathy. Diabetes Care 5: 386–390
Fedele D, Bellavere F, Cardone C, Ferri M, Crepaldi G (1985) Improvement of cardiovascular autonomic reflexes after amelioration of metabolic control in insulin-dependent diabetic subjects with severe autonomic neuropathy. Horm Metabol Res 17: 410–413
Ziegler D, Mayer P, Muhlen H, Gries FA (1991) The natural history of somatosensory and autonomic nerve dysfunction in relation to glycaemic control during the first 5 years after diagnosis of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 34: 822–829
Pryce TD (1893) On diabetic neuritis with a clinical and pathological description of three cases of diabetic pseudo-tabes. Brain 16: 416–424
Woltman HW, Wilder RM (1929) Diabetes mellitus pathological changes in the spinal cord and peripheral nerves. Arch Intern Med 44: 576–603
Fagerberg SE (1959) Diabetic neuropathy: a clinical and histological study on the significance of vascular affections. Acta Med Scand 164 [Suppl 345]: 5–81
Bischoff A (1980) Morphology of diabetic neuropathy. Horm Metab Res 9 [Suppl]: 18–28
Brownlee M, Cerami A, Vlassara H (1988) Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318: 1315–1321
Malik RA, Veves A, Masson EA et al. (1992) Endoneurial capillary abnormalities in mild human diabetic neuropathy. J Neurol Neurosurg Psychiatry 55: 557–561
Powell HC, Rosoff J, Myers RR (1985) Microangiopathy in human diabetic neuropathy. Acta Neuropathol (Berl) 68: 295–305
Yasuda H, Dyck PJ (1987) Abnormalities of endoneurial micro vessels and sural nerve pathology in diabetic neuropathy. Neurology 37: 20–28
Malik RA, Newrick PG, Sharma AK et al. (1989) Microangiography in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia 32: 92–102
Britland ST, Young RJ, Sharma AK, Clarke BF (1990) Relationship of endoneurial capillary abnormalities to type and severity of diabetic polyneuropathy. Diabetes 39: 909–913
Malik RA, Tesfaye S, Thompson SD et al. (1993) Endoneurial localisation of microvascular damage in human diabetic neuropathy. Diabetologia 36: 454–459
Timperly WR, Ward JD, Preston FE, Duckworth T, O'Malley BC (1976) Clinical and histological studies in diabetic neuropathy. Diabetologia 12: 237–243
Williams E, Timperly WR, Ward JD, Duckworth T (1980) Electronmicroscopical studies of vessels in diabetic peripheral neuropathy. J Clin Pathol 33: 462–470
Timperly WR, Boulton AJM, Davies Jones GAB, Jarrat JA, Ward JD (1985) Small vessel disease in progressive diabetic neuropathy associated with good metabolic control. J Clin Pathol 38: 1030–1038
Dyck PJ, Hansen S, Karnes J et al. (1985) Capillary number and percentage closed in human diabetic sural nerve. Proc Nat Acad Sci (USA) 82: 2513–2517
Malik RA, Tesfaye S, Thompson SD et al. (1994) Transperineurial capillary abnormalities in the sural nerve of patients with diabetic neuropathy. Microvascular Res [In Press]
Ford I, Malik RA, Newrick PG, Preston FE, Ward JD, Greaves M (1992) Relationship between haemostatic factors and capillary morphology in human diabetic neuropathy. Thromb Haemost 68: 628–633
Newrick PG, Wilson AJ, Jakubowski J, Boulton AJM, Ward JD (1986) Sural nerve oxygen tension in diabetes. BMJ 293: 1053–1054
Johnson PC, Doll SC, Cromey DW (1986) Pathogenesis of diabetic neuropathy. Ann Neurol 19: 450–457
Beggs J, Johnson PC, Olafsen A, Watkins CL, Cleary C (1991) Transperineurial arterioles in human sural nerve. J Neuropathol Exp Neurol 6: 704–718
Dyck PJ, Karnes JL, O'Brien P, Okazaki H, Lias A, Engelstad J (1986) The spatial distribution of fibre loss in diabetic polyneuropathy suggests ischaemia. Ann Neurol 19: 440–449
Dyck PJ, Lais A, Karnes JL, O'Brien P, Rizza R (1986) Fibre loss is primary and multifocal in sural nerves in diabetic polyneuropathy. Ann Neurol 19: 425–439
Asbury AK, Aldredge H, Hershberg R, Fisher CM (1970) Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain 93: 555–566
Raff MC, Sangalang V, Asbury AK (1968) Ischaemic mononeuropathy multiplex associated with diabetes mellitus. Arch Neurol 18: 487–499
Korthals JK, Gieron MA, Dyck PJ (1988) Intima of epineurial arterioles is increased in diabetic polyneuropathy. Neurology 38: 1582–1586
Roberts JT (1948) The effect of occlusive arterial disease of the extremities of the blood supply of nerves: experimental and clinical studies on the vasa nervorum. Am Heart J 35: 369–392
Korthals JK, Wisniewski HM (1975) Peripheral ischaemia. I. Experimental model. J Neurol Sci 24: 65–76
Nukada H, Dyck PJ (1984) Microsphere embolization of nerve capillaries and fibre degeneration. Am J Pathol 115: 275–287
Benstead TJ, Sangalang VE, Dyck PJ (1990) Acute endothelial swelling is induced in endoneurial microvessels by ischaemia. J Neurol Sci 99: 37–49
Tuck RR, Schmelzer JD, Low PA (1984) Endoneurial blood flow and oxygen tension in the sciatic nerves of rats with experimental diabetic neuropathy. Brain 107: 935–950
Cameron NE, Cotter MA, Low PA (1991) Nerve blood flow in early experimental diabetes in rats: relation to conduction deficits. Am J Physiol 261: E1-E8
Cameron NE, Cotter MA, Ferguson K, Robertson S, Radcliffe MA (1991) Effects of chronic alpha-adrenergic receptor blockade on peripheral nerve conduction, hypoxic resistance, polyols, Na+-K+-ATPase activity and vascular supply in STZ-D rats. Diabetes 40: 1652–1658
Cameron NE, Cotter MA, Robertson S (1992) Angiotensin converting enzyme inhibition prevents the developments of muscle and nerve dysfunction and stimulates angiogenesis in streptozotocin-diabetic rats. Diabetologia 35: 12–18
Low PA, Tuck RR, Dyck PJ, Schmelzer JD, Yao JK (1984) Prevention of some electrophysiologic and biochemical abnormalities with oxygen supplementation in experimental diabetic neuropathy. Proc Natl Acad Sci USA 81: 6894–6898
Low PA, Schmelzer JD, Ward KK, Curran GL, Poduslo JF (1988) Effect of hyperbaric oxygenation on normal and chronic streptozotocin diabetic peripheral nerves. Exp Neurol 99: 201–212
Low PA, Schmelzer JD, Ward KK, Yao JK (1986) Experimental chronic hypoxic neuropathy: relevance to diabetic neuropathy. Am J Physiol 250: E94-E99
Benstead TJ, Dyck PJ, Low P (1988) Chronic hypoxia induces selective maldevelopment of peripheral myelin in rat. J Neuropathol Exp Neurol 47: 599–608
Smith WJ, Diemel LT, Leach RM, Tomlinson DR (1991) Central hypoxaemia in rats provokes neurological defects similar to those seen in experimental diabetes mellitus: evidence for a partial role of endoneurial hypoxia in diabetic neuropathy. Neuroscience 45: 255–259
Stevens EJ, Lockett MJ, Carrington AL, Tomlinson DR (1993) Essential fatty acid treatment prevents nerve ischaemia and associated conduction anomalies in rats with experimental diabetes mellitus. Diabetologia 36: 397–401
Yasuda H, Sonobe M, Yamashita M et al. (1989) Effect of prostaglandin E1 analogue TFC 612 on diabetic neuropathy in streptozotocin-induced diabetic rats: comparison with aldose reductase inhibitor ONO 2235. Diabetes 38: 832–838
Stevens EJ, Carrington AL, Tomlinson DR (1994) Nerve ischaemia in diabetic rats: time-course of development, effect of insulin treatment plus comparison of streptozotocin and BB models. Diabetologia 37: 43–48
Pugliese G, Tilton RG, Williamson JR (1991) Glucose-induced metabolic imbalances in the pathogenesis of diabetic vascular disease. Diabetes Metab Rev 7: 35–59
Williamson JR, Chang K, Allison W, Kilo C (1993) Endoneurial blood flow changes in diabetic rats. Diabetic Med 10 [Suppl 2]: 49S-51S
Monafo WW, Eliasson SV, Shimazaki S, Sugimoto H (1988) Regional blood flow in resting and stimulated sciatic nerve of diabetic rats. Exp Neurol 99: 607–614
Boulton AJM, Scarpello JHB, Ward JD (1982) Venous oxygenation in the diabetic neuropathic foot: evidence of arterio-venous shunting? Diabetologia 22: 6–8
Tesfaye S, Harris N, Jakubowski J et al. (1993) Impaired blood flow and arterio-venous shunting in human diabeic neuropathy: a novel technique of nerve photography and fluorescein angiography. Diabetologia 36: 1266–1274
Llewelyn JG, Thomas PK, Fonseca V, King RHM, Dandona P (1986) Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol (Berl) 72: 157–163
Ward JD, Simms JM, Knight G, Boulton AJM, Sandler DA (1983) Venous distension in the diabetic neuropathic foot (physical sign of arterio-venous shunting). J Roy Soc Med 76: 1011–1014
Edmonds ME, Roberts VC, Watkins PJ (1982) Blood flow in the diabetic neuropathic foot. Diabetologia 22: 9–15
Van-den-Hoogen F, Brawn LA, Sherriff S, Watson N, Ward JD (1986) Arteriovenous shunting in quadriplegia. Paraplegia 25: 282–286
Tesfaye S, Harris N, Wilson RM, Ward JD (1992) Exercise induced conduction velocity increment: a marker of impaired nerve blood flow in diabetic neuropathy. Diabetologia 35: 155–159
Greaves M, Preston FE (1984) Haemostatic abnormalities in diabetes. In: Jarrett RJ (ed) Metabolic aspects of cardiovascular disease 2. Diabetes and heart disease. Oxford: Elsevier, pp 47–80
O'Mally BC, Timperly WR, Ward JD, Porter NR, Preston FE (1975) Platelet abnormalities in diabetic neuropathy. Lancet II: 1274–1276
McMillan DE, Utterback NG, La Puma J (1978) Reduced erythrocyte deformability in diabetes. Diabetes 27: 895–901
Wautier J-L, Paton RC, Wautier MP et al. (1981) Increased adhesion of erythrocytes to endothelial cells in diabetes mellitus and its relation to vascular complications. N Eng J Med 305: 237–242
Baba Y, Kai M, Kamanda T, Setoyama S, Otsugi S (1979) Higher levels of erythrocyte membrane microviscosity in diabetes. Diabetes 28: 1138–1140
McMillan DE (1982) Further observations in serum viscosity change in diabetes mellitus. Metabolism 31: 274–278
Steiness IB (1961) Influence of diabetic status on VP during ischaemia. Acta Med Scad 170: 319
Newrick PG, Boulton AJM, Ward JD (1987) Nerve ischaemia resistance: an early abnormality in diabetes. Diabetic Med 4: 517–520
Low PA, Ward KK, Schmelzer JD et al. (1985) Relationship of resistance to ischaemic conduction failure to energy metabolism in experimental diabetic neuropathy. Am J Physiol 248: E457-E462
Masson EA, Church SE, Woodcock AA, Hanley SP, Boulton AJM (1988) Is resistance to ischaemic conduction failure induced by hypoxia? Diabetologia 31: 762–765
Appenzeller O, Dhital KK, Cowen T, Burnstock G (1984) The nerve to blood vessels supplying blood to nerves: the innervation of the vasa nervorum. Brain Research 304: 383–386
Malik RA, Masson EA, Sharma AK et al. (1990) Hypoxic neuropathy: relevance to human diabetic neuropathy. Diabetologia 33: 311–318
Stoebner P, Mezin P, Vila A, Grosse R, Kopp N, Paramelle B (1989) Microangiopathy of endoneurial vessels in hypoxemic chronic obstructive pulmonary disease. Acta Neuropathol 78: 388–395
Robertson S, Cameron NE, Cotter NA (1992) The effect of calcium antagonist nifedipine on peripheral nerve function in streptozotocin-diabetic rats. Diabetologia 35: 1113–1117
Hotta N, Kakuta H, Fakasawa H et al. (1992) Effect of niceritrol on streptozotocin-induced diabetic neuropathy in rats. Diabetes 41: 587–591
Maxfield EK, Cameron NE, Cotter MA, Dines KC (1993) Angiotensin II receptor blockade improves nerve function, modulates nerve blood flow and stimulates endoneurial angiogenesis in streptotocin-diabetic rats. Diabetologia 36: 1230–1237
Low PA, Kihara M, Cameron N, Cotter J, Poduslo J (1993) Cause and effect of ischaemia in chronic experimental diabetic neuropathy. Diabetic Med 10 [Suppl 2]: 52S-55S
Bravenboer B, Kappelle AC, Hamers FPT, van Buren T, Erkelens DW, Gispen WH (1992) Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-induced diabetic rat. Diabetologia 35: 813–817
Low PA, Nickander KK (1991) Oxygen free radical effects in sciatic nerve in experimental diabetes. Diabetes 40: 873–877
Cameron NE, Cotter MA, Archibald V, Dines KC, Maxfield EK (1994) Anti-oxidant and pro-oxidant effects on nerve conduction velocity, endoneurial blood flow and oxygen tension in non-diabetic and streptozotocin-diabetic rats. Diabetologia 37: 449–459
Jamal GA, Carmichael H (1990) The effect of gammalinolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial. Diabetic Med 7: 319–323
Cameron NE, Cotter MA, Robertson S (1991) Essential fatty acid diet supplementation: effects on peripheral nerve and skeletal muscle function and capillarization in streptozotocin-induced diabetic rats. Diabetes 40: 532–539
Reja A, Tesfaye S, Harris N, Ward JD (1993) Improvement in nerve conduction and quantitative sensory tests after treatment with lisinopril. Diabetic Med 10 [Suppl 3]: S18 (Abstract)
Young MJ, Veves A, Walker MG, Boulton AIM (1992) Correlations between nerve function and tissue oxygenation in diabetic patients: further clues to the aetiology of diabetic neuropathy? Diabetologia 35: 1146–1150
Baynes JW (1991) Role of oxidative stress in the development of complications in diabetes. Diabetes 40: 405–412
Corbett JA, Tilton RG, Chang K et al. (1992) Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552–556
McVeigh GE, Brennan GM, Johnston GD et al. (1992) Impaired endothelium-dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 35: 771–776
Tooke JE (1986) Microvascular haemodynamics in diabetes mellitus. Clin Sci 70: 119–125
Gabbay KH, Merola LO, Field RA (1966) Sorbitol pathway: presence in nerve and cord with substrate accumulation in diabetes. Science 151: 209–210
Ward JD, Baker RWR, Davis B (1972) Effect of blood sugar control on the accumulation of sorbitol and fructose in nervous tissue. Diabetes 21: 1173–1178
Dyck PJ, Zimmerman BR, Todd HV et al. (1988) Nerve glucose, fructose, sorbitol, myo-inositol and fibre degeneration and regeneration in diabetic neuropathy. N Engl J Med 319: 542–548
Greene D, Lattimer SA, Sima AAF (1987) Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med 316: 599–606
Greene D, Lattimer SA (1983) Impaired rat sciatic nerve sodium-potassium-ATPase in acute streptozotocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest 72: 1058–1063
Das PK, Bray GM, Aguayo AJ, Rasminisky M (1976) Diminished ouabain-sensitive, sodium-potassium-ATPase activity in sciatic nerves of rats with streptozotocin-induced diabetes. Exp Neurol 53: 285–288
Spritz N, Marinan B, Singh H (1974) Effects of insulin on the incorporation of 14-C leucine into the protein components of sciatic nerve myelin. Diabetes 23: 358
Sidenius P, Jakobson J (1987) Axonal transport in human and experimental diabetes. In: Dyck PJ, Thomas PK, Asbury AK, Winegrad AI, Porte D (eds). Diabetic neuropathy. Philadelphia: WB Saunders 260–265
Ishii DN (1993) Insulin and related neurotrophic factors in diabetic neuropathy. Diabetic Med 10 [Suppl 2]: 14S-15S
Schmidt RE (1993) The role of nerve growth factor in the pathogenesis and therapy of diabetic neuropathy. Diabetic Med 10 [Suppl 2]: 10S-13S
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tesfaye, S., Malik, R. & Ward, J.D. Vascular factors in diabetic neuropathy. Diabetologia 37, 847–854 (1994). https://doi.org/10.1007/BF00400938
Issue Date:
DOI: https://doi.org/10.1007/BF00400938